Latest Clinical Trials
Society’s view of disability has undergone a tectonic shift over the last century or so. Where once disability was feared and imagined to be the result of divine wrath, disability is now increasingly normalized in society. We see hallmarks of this in everyday life: special lifts for those who are less mobile, as well as…
Once regarded as nonexistent, the multiple sclerosis prodrome can help physicians prepare for an eventual diagnosis of the disease.
The best way to develop a comprehensive therapeutic strategy for patients with multiple sclerosis is in a multidisciplinary setting.
Cognitive impairment (CI) is not a given for every person living with multiple sclerosis (MS).
For persons living with multiple sclerosis (MS), daily life consists of a host of challenges, and cognitive impairment (CI) is the primary one among them.
The definition of multiple sclerosis (MS) itself describes one of the challenges of this chronic illness.
Gamida Cell is gearing up to begin sales of omidubicel from Israel to US hospitals for use in stem cell transplants, pending FDA approval of the therapy.
Dr. Rahul Banerjee of the University of Washington discusses the benefits and drawbacks of using synthetic control arms in randomized controlled trials.
The Alliance for Regenerative Medicine aims to help in the development of safe and effective regenerative therapies that can benefit rare disease patients.
Mind, Mood and Memory: The Neurobehavioral Consequences of Multiple Sclerosis explains the potential benefits of cognitive rehabilitation in people with MS.